Check out our news

Get our newsletters

Published on the 10 July 2020

Let’s get back on track together!

Have your preclinical R&D projects fallen behind schedule during lockdown? Every industrial activity has been knocked sideways by the COVID-19 emergency – and healthcare R&D is no exception…

Company
Published on the 16 June 2020

B2B meetings at BIO-Digital

A fast-paced week filled with opportunities! Thanks to everyone we met – we really appreciated the quality of our discussions, and are as excited as ever to be working alongside you on your #stroke…

Events
Published on the 15 June 2020

B2B meetings at BIO-Digital: A fast-paced week filled with opportunities!

Thanks to everyone we met – we really appreciated the quality of our interactions, and are as excited as ever to be working alongside you on your preclinical projects. Thanks also to Business Franc…

Events
Published on the 3 June 2020

Meet us at BIO-Digital, 8-12 june

Strok@lliance will participate at Bio-Digital next 8-12 June. Our expert Dr. Nicolas Violle (CEO) will present ETAP-Lab’s services in the field of preclinical Stroke. Please feel free to reach out …

Events
Published on the 3 June 2020

Meet us at BIO-Digital, 8-12 june

ETAP-Lab will participate at Bio-Digital next 8-12 June. Our experts Dr. Jean-François BISSON (VP) and Dr. Nicolas Violle (CEO) will present ETAP-Lab’s services in the fields of preclinical Dermatolog…

Events
Published on the 8 April 2020

COVID-19: Business Continuity

We hope that you are not being too hard hit by the current crisis, and that you and your family and friends remain healthy. Like many others, we have reorganized our production schedule to ensure c…

Company
Published on the 8 April 2020

COVID-19: Business Continuity

We hope that you are not being too hard hit by the current crisis, and that you and your family and friends remain healthy. Like many others, we have reorganized our production schedule to ensure c…

Company
Published on the 10 February 2020

ETAP-Lab’s dermatology activity keeps growing: our first project with a US-based company

By entrusting development of its drug candidate to our expertise, a NASDAQ-listed North American company is following the lead of European and Asian businesses by choosing ETAP-Lab’s DNCB-induced atop…

Company

Explore our scientific resources and browse posters…

Explore our resources